{
  "id": "ic-c7",
  "version": "1",
  "drug": {
    "slug": "doacs",
    "display": "DOACs (apixaban, rivaroxaban, dabigatran, edoxaban)"
  },
  "supplement": {
    "slug": "ginkgo-biloba",
    "display": "Ginkgo biloba"
  },
  "severity": "moderate",
  "evidenceTier": "label-mechanistic",
  "mechanism": "The bleeding mechanism documented for ginkgo with warfarin applies without an INR to watch; DOAC monitoring is harder, which raises practical caution.",
  "patientNotes": [
    "Avoid ginkgo on a DOAC unless your prescriber says otherwise.",
    "Bleeding signs deserve a prompt call."
  ],
  "pmids": [
    "26958257"
  ],
  "pubmedUrls": [
    "https://pubmed.ncbi.nlm.nih.gov/26958257/"
  ],
  "guideSlugs": [],
  "guideUrls": [],
  "pairUrl": "https://supplementbrief.com/interactions/doacs/ginkgo-biloba/",
  "reviewedBy": "natallia-kalistratava",
  "reviewerUrl": "https://supplementbrief.com/authors/natallia-kalistratava/",
  "lastVerified": "2026-08-18",
  "jsonUrl": "https://supplementbrief.com/data/v1/pairs/ic-c7.json",
  "htmlUrl": "https://supplementbrief.com/data/v1/pairs/ic-c7/"
}
